US$ 20.87
glp 1 agonist osteoporosis Treatment of Diabetes and Osteoporosis—A Reciprocal Risk? GLP-1 receptor agonists could protect
Description
Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes

Gastric ultrasound identifies increased residual gastric contents in patients on GLP-1 receptor agonists, showing that shorter drug withholding and fasting times are linked to higher aspiration risk before anesthesia.

Prospective ultrasound studies show a higher prevalence of residual gastric content in GLP-1 RA users, particularly during dose escalation or when GI symptoms are present

$4,800-7,200 for Pharmaceutical GLP-1LAKELAND, Dec

What if it doesnt work for me?

This analysis was part of the IMI-Stratification of Obesity Phenotypes to Optimize Future Obesity Therapy (IMI-SOPHIA) project
